Originally published In Press as doi:10.1074/jbc.M001936200 on April 4, 2000
J. Biol. Chem., Vol. 275, Issue 24, 18034-18039, June 16, 2000
Kinetic and Mutational Analyses of the Regulation of
Phosphoribulokinase by Thioredoxins*
Mary K.
Geck
§ and
Fred C.
Hartman¶
From the
University of Tennessee-Oak Ridge Graduate
School of Biomedical Sciences and the ¶ Protein Engineering
Program, Life Sciences Division, Oak Ridge National Laboratory,
Oak Ridge, Tennessee 37831
Received for publication, March 8, 2000, and in revised form, April 2, 2000
 |
ABSTRACT |
Despite little supportive data, differential
target protein susceptibility to redox regulation by thioredoxin (Trx)
f and Trx m has been invoked to account for two
distinct Trxs in chloroplasts. However, this postulate has not been
rigorously tested with phosphoribulokinase (PRK), a fulcrum for redox
regulation of the Calvin cycle. Prerequisite to Trx studies, the
activation of spinach PRK by dithiothreitol, 2-mercaptoethanol, and
glutathione was examined. Contrary to prior reports, each activated
PRK, but only dithiothreitol supported Trx-dependent
activation. Comparative kinetics of activation of PRK showed Trx
m to be more efficient than Trx f because of
its 40% higher Vmax but similar
S0.5. Activations were insensitive to
ribulosebisphosphate carboxylase, which may complex with PRK in
vivo. To probe the basis for superiority of Trx m, we
characterized site-directed mutants of Trx f, in which
unique residues in conserved regions were replaced with Trx
m counterparts or deleted. These changes generally resulted
in Vmax enhancements, the largest (6-fold) of
which occurred with T105I, reflective of substitution in a hydrophobic
region that opposes the active site. Inclusive of the present study,
activation kinetics of several different Trx-regulated enzymes indicate
redundancy in the functions of the chloroplastic Trxs.
 |
INTRODUCTION |
The discovery (1, 2) that
Trx1 mediates the light
regulation of various chloroplastic enzymes provided an explanation at
the molecular level for the correlation between light intensity and the
capacity for CO2 assimilation by photosynthetic organisms (for reviews see Refs. 3 and 4). In the light, electron flow through
ferredoxin and ferredoxin-thioredoxin reductase maintains Trx in its
reduced state, in which vicinal active site sulfhydryls prevail.
Reduced Trx can then reduce the regulatory disulfides of target enzymes
via sulfhydryl-disulfide exchange. Such reduction activates susceptible
biosynthetic enzymes but inactivates susceptible biodegradative
enzymes, thereby minimizing the simultaneous functioning of opposing
metabolic pathways (5).
Shortly after the discovery of the ferredoxin-thioredoxin pathway for
enzyme regulation, two distinct chloroplastic thioredoxins (denoted Trx
f and Trx m) were isolated and characterized (6). The physiological need for two thioredoxins appeared to be a
consequence of their preferential selectivity among the array of target
enzymes. For example, under the assay conditions described, Trx
f was more effective in the activation of
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,
fructose-1,6-bisphosphatase, sedoheptulose 1,7-bisphosphatase, and PRK,
whereas Trx m displayed a preference for NADP-dependent malate dehydrogenase and glucose-6-phosphate dehydrogenase (3, 4,
6-9). Armed with this background, we initiated an effort to identify
recognition and selectivity determinants of Trx f by
utilization of site-directed mutagenesis. During the course of our
earlier study (10), we demonstrated that Trx f is
kinetically superior to Trx m as an activator for both
fructose-1,6-bisphosphatase and NADP-dependent malate dehydrogenase.
Because this unexpected finding contradicted the generally accepted
explanation for the presence of two chloroplastic thioredoxins, we felt
it only prudent to extend kinetic analyses to another redox-sensitive
enzyme and accordingly have selected PRK.
PRK catalyzes the ATP-dependent phosphorylation of
D-ribulose 5-phosphate to form
D-ribulose-1,5-bisphosphate, the requisite acceptor of
CO2 in photosynthetic carbon fixation. This chloroplast enzyme, a homodimer with a subunit molecular weight of ~40,000 (11),
is reversibly inactivated by formation of an intrasubunit disulfide
between Cys16 and Cys55 (12). Even though both
of these regulatory cysteinyl residues are located in the ATP-binding
domain of the active site, neither is crucial to activity. The free
sulfhydryl of Cys55 is only moderately facilitative of
catalysis, whereas that of Cys16 has no effect whatsoever
on activity (13). Total loss of kinase activity, which accompanies
oxidation, reflects a combination of masking the sulfhydryl of
Cys55 and introducing a conformational constraint as
imposed by the disulfide (13, 14).
Several observations provide evidence that PRK is indeed
redox-regulated in vivo by Trx. These include Trx dependence
of light activation of PRK in reconstituted systems (2, 6), correlative increases and decreases in the level of the kinase activity in isolated
chloroplasts during successive light-dark cycles (15-19), activation
of purified preparations of PRK by Trx (6), and covalent complexation
by highly selective disulfide bridging of Cys46 of Trx
f with Cys55 of PRK (20). However, the relative
kinetic efficiency of Trx f and Trx m in the
activation of purified PRK has not been determined. Herein, we report
such a comparison and also the effectiveness of several site-directed
mutants of Trx f, designed to more closely resemble Trx
m, as activators of PRK. Several of the mutant thioredoxins (K58E,
N74, N74D, Q75D, and
N77) were described in our earlier report with respect to their ability to activate NADP-dependent malate
dehydrogenase and fructose-1,6-bisphosphatase (10). Additionally, two
newly engineered variants of Trx f are also examined: T105I and the double mutant V89I/T105I.
 |
EXPERIMENTAL PROCEDURES |
Materials--
The following materials were obtained from the
sources indicated: DTNB, Fisher Scientific; DTT and buffers, Research
Organics; and PRK assay reagents, bovine serum albumin, and BME, Sigma. Spinach Rubisco was purified according to a published protocol (21).
Construction, expression, and purification of recombinant Trx
f and many of the site-directed mutants thereof used in the present study have been described (10). Two new site-directed mutants
were generated using this previously published protocol and the
following primers: pGGCATCAGAGTAATTCCTACTTTCAAGATT for V89I conversion
and the aforementioned primer in conjunction with pGTGGGAGAAGTTATAGGGGCAAAATATGAT for V89I/T105I. These
electrophoretically pure protein preparations (>5 mg/ml) were stored
at
80 °C in 50 mM Bicine-NaOH (pH 8.0), 0.1 mM EDTA, 20% (v/v) glycerol, 5 mM
DTT. Purified recombinant spinach Trx m was kindly provided by Professor Peter Schürmann of the Université de
Neuchâtel in Switzerland. The sample, received in lyophilized
form, was resuspended in 50 mM Bicine-NaOH (pH 8.0), 0.1 mM EDTA, 20% (v/v) glycerol, 5 mM
DTT to a final concentration of ~5 mg/ml, dialyzed overnight against
the same buffer, and stored at
80 °C prior to use. During the
course of the present study, authentic PRK isolated from spinach leaves
(11, 12) and recombinant spinach PRK isolated from transformed
Pichia pastoris (13, 22) were both used. In all cases, the
preparations were virtually homogenous and indistinguishable as judged
by denaturing polyacrylamide gel electrophoresis. However, their
specific activities were somewhat variable, ranging from 260 to 358 units/mg. Prior to DTNB-oxidative inactivation of PRK to prepare the
substrate for the Trx activation studies (see below), the preparations
of PRK (>20 mg/ml) were stored at
80 °C in 40 mM
Bicine-KOH (pH 8.0), 0.8 mM EDTA, 20% (v/v) glycerol, 10 mM DTT. Typically, the inactive DTNB-oxidized samples
regained 90-95% of their original activity upon incubation with 50 mM DTT for 15 min.
Oxidation of PRK--
Prior to oxidation of PRK, exogenous thiol
was removed from the purified preparation by gel filtration on Sephadex
G-25 equilibrated with 40 mM Bicine-KOH (pH 8.0), 0.8 mM EDTA. Oxidation was then performed by treatment of PRK
(3-10 mg/ml) with a 20% molar excess (relative to subunit
concentration) of DTNB at 25 °C until PRK activity could no longer
be detected (~5 min). The DTNB reaction mixture was then exhaustively
dialyzed against 50 mM Bicine-KOH (pH 8), 1 mM
EDTA, 20% (v/v) glycerol. Stock solutions of the oxidized kinase were
stored at
80 °C at a concentration of approximately 5 mg/ml.
Previous studies have demonstrated that the loss of kinase activity
upon incubation with DTNB is concomitant with the formation of a single
disulfide bond per subunit of PRK between Cys16 and
Cys55, with no other modifications detected (12). Thus,
DTNB-oxidized PRK can be regarded as comparable with the enzyme present
in the darkened chloroplast.
Activation of PRK--
PRK (0.08 mg/ml, 2 µM
subunit) was activated at 25 °C by the indicated concentrations of
DTT, BME, GSH, or Trx (in the presence of low molecular weight thiol)
in buffered solutions (25 µl) of 40 mM Bicine-KOH (pH
8.0) and 0.8 mM EDTA. Periodically, 5-µl aliquots were
withdrawn for the determination of kinase activity at 25 °C. Assay
solutions (1 ml) consisted of 50 mM Bicine-KOH (pH 8.0), 40 mM KCl, 10 mM MgCl2, 1 mM ATP, 3 mM phosphoenolpyruvate, 0.3 mM NADH, 5 units of pyruvate kinase, 6 units of lactate
dehydrogenase, 0.8 mM ribulose 5-phosphate. The latter was
prepared by incubation of 150 mM ribose 5-phosphate and
approximately 2 units of the phosphoriboisomerase at room temperature
for 30 min in 1.3 ml of 50 mM Bicine-KOH (pH 8.0), 40 mM KCl, 10 mM MgCl2; 20 µl of this solution was used per 1-ml assay. The formation of
NAD+ was followed spectrophotometrically at 340 nm. One
unit of PRK activity corresponds to an absorbance change of 6.22/min.
When activation rates are expressed as milliunits/min, the reflected amount of protein is 2.0 µg.
 |
RESULTS |
Activation of PRK by Low Molecular Weight Thiols--
Several
considerations prompted the inclusion of a low molecular weight thiol
in reaction mixtures for the examination of the activation of PRK by
Trx. Because the redox potentials of PRK, Trx f, and Trx
m are virtually identical (23), complete activation of
oxidized PRK will not occur upon incubation with Trx. Furthermore, even
with rather stringent precautions to mitigate oxidation, aqueous
solutions of reduced Trx tend to accumulate some of the oxidized form,
which will further impede activation of PRK. Finally, maintaining all
of the Trx in its reduced state is necessary to achieve pseudo
first-order kinetics of activation of PRK and thus accurate
determination of those kinetic parameters being sought.
Inclusion of an exogenous thiol in PRK-Trx reaction mixtures does,
however, introduce an unavoidable complication because of the potential
for PRK activation by the added thiol. PRK is known to undergo
activation by DTT (2, 15, 18), but the associated kinetics have not
been thoroughly examined. Thus, prerequisite to analyses of
Trx-dependent activation of PRK, the rate at which DTT
activates PRK was quantified. The abilities of BME and GSH to activate
PRK were also determined in an effort to identify a reagent that was
unable to activate PRK but would nevertheless maintain Trx in its
reduced state.
At rather high concentrations, GSH (100 mM) and the
nonphysiological reductants DTT (20 mM) and BME (50 mM) are all capable of fully activating PRK (Fig.
1). The somewhat slower rates observed with the two monothiols are consistent with their lower reduction potentials relative to that of DTT (24-26). Lower concentrations of
the thiols (e.g. 2 mM), despite ~1000-fold
molar excess over PRK, lead to only partial activation, presumably
because of establishment of equilibrium. With DTT and BME, the initial
rates of activation were directly proportional to the concentration of
reductant (i.e. pseudo first-order kinetics); the calculated
second-order rate constants (k2nd) were 5.4 M
1 min
1 for DTT and 0.7 M
1 min
1 for BME. By contrast,
activation of PRK by GSH, either alone or in the presence of a fixed
concentration of DTT, exhibits saturation kinetics with respect to the
concentration of GSH (Fig. 2). In the
absence of DTT, k2nd was 0.6 M
1 min
1 with a
Vmax of 20 milliunits/min and an
S0.5 of 24 mM. In the presence of 4 mM DTT, k2nd was 2.9 M
1 min
1 with a
Vmax of 12 milliunits/min and an
S0.5 of 5 mM. The plot in Fig. 2,
from which these latter values are derived, is corrected for the
contribution of DTT to the activation.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Activation of oxidized PRK by various
reductants. Time courses of activation by various concentrations
of DTT (A), BME (B), and GSH (C) are
shown.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Initial rates of PRK activation by GSH in the
absence ( ) and presence ( ) of 4 mM DTT. Data
were fit to the simplified Hill equation of v = Vmax[S]n/(K' + [S]n), whereby n is the calculated value for the
apparent number of binding sites. The activation data points shown with
GSH in the presence of DTT have been corrected for the extent of
activation brought about by 4 mM DTT alone.
|
|
Because each of the thiols tested is able to activate the oxidized form
of PRK, the enhancements of activation rates by Trx f
against a background of DTT (0.5 mM) or BME (2 mM) were compared. As shown in Fig.
3, very little differential activation by
Trx occurs in the presence of BME, whereas dramatic stimulation of activation takes place in the presence of DTT. Apparently, the reduction potential of BME is insufficient to maintain all of the Trx
in the reduced form. Likewise, Trx f provided little
enhancement of PRK activation as induced by GSH (data not shown). Thus,
subsequent activation kinetics of PRK by Trx were determined in the
presence of 4 mM DTT to ensure that Trx remained fully
reduced.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Impact of wild-type Trx f on
the activation rate of PRK in the presence of low molecular weight
thiols. Time courses of activation by 0.5 mM DTT
( ); 0.5 mM DTT + 50 µM Trx f
( ); 2 mM BME ( ); and 2 mM BME + 50 µM Trx f ( ) are shown.
|
|
Comparative Kinetics of the Activation of PRK by Trx f and Trx
m--
To determine the dependence of activation rate on the
concentration of Trx, molar ratios of [Trx]/[PRK]
5 were used so
that [Trx]free would approximate [Trx]total
and activation kinetics would be pseudo-first-order. Estimation of
initial rates of activation was based on data collected over the range
of 0-30% of the full activation level having been achieved. This
range represents the linear phase of the activation curves. The
Trx-dependent rate of activation (i.e. the
activation rate corrected for the basal rate because of DTT alone) did
not vary significantly in the presence of 1-4 mM DTT,
thereby verifying that Trx remained fully reduced throughout the course
of PRK activation.
Initial rates of activation, extracted from time courses and corrected
for the contribution of DTT, are plotted as a function of Trx
f or Trx m concentration in Fig.
4. The Trx concentration dependence
curves exhibit sigmoidicity, as typifies interactions of Trx with
target proteins (10, 27-29). The plot shown for Trx f
yields an S0.5 of 17 µM and a
Vmax of 7 milliunits/min. Trx m is
modestly more efficient than Trx f as an activator of PRK because of its higher Vmax (11 milliunits/min)
but virtually identical S0.5 (15 µM). In another kinetic study with Trx f in
which the activation mixture contained a 10-fold lower concentration of oxidized PRK (i.e., 0.2 µM subunit), very
similar S0.5 and Vmax values were obtained (data not shown).

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 4.
Activation of PRK by wild-type chloroplastic
thioredoxins. Initial rates of PRK activation by the specified
type and concentration of Trx are represented by individual data
points. These initial rates are thioredoxin-dependent rates
of activation, calculated by subtracting the background rate of
activation by 4 mM DTT alone from the rate in the presence
of both Trx and DTT. Curve fittings were performed as in Fig. 2.
, Trx f; , Trx
m.
|
|
Because of literature reports that implicate in vivo
complexation of PRK with various chloroplast proteins, including
D-ribulose-1,5-bisphosphate carboxylase/oxygenase (reviewed
in Ref. 30), the potential influence of this protein on the activation
of PRK by Trx f and Trx m were determined. In a
separate experiment, bovine serum albumin was used as a generic protein
to substitute for the carboxylase. Neither the carboxylase (at 2-fold
molar excesses relative to PRK subunits) nor bovine serum albumin (at
8-fold molar excess) significantly stimulates the activation of PRK by
either thioredoxin (data not shown).
The site-directed mutants of Trx f, designed to be more akin
to Trx m, were also analyzed kinetically in the activation
of PRK; in all cases the Trx concentration dependence curves were sigmoidal as with the wild-type proteins and qualitatively analogous to
those illustrated for T105I and V89I/T105I in Fig.
5. The derived kinetic parameters for all
of the mutants are compiled in Table I.
All of the mutants are somewhat impaired with respect to binding of
PRK, as judged by their S0.5 values, which range
from 1.4- to 5-fold greater than that of wild-type Trx f.
Except for K58E, the mutants display enhanced
Vmax values. However, in the cases of N74D,
N74,
N77, and Q75D, the increased rates of reduction of PRK are
counterbalanced by the weakened interactions with PRK, whereby the
overall efficiencies of activation (i.e.
Vmax/S0.5 values) are
virtually unchanged or decreased about 2-fold. Only with T105I and
V89I/T105I are the efficiencies of activation increased.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
Activation of PRK by site-directed mutants of
Trx f. Initial rates of PRK activation by the
variants T105I ( ) and V89I/T105I ( ). Experiments were performed
as Fig. 4, and the thioredoxin-dependent rates of
activation are shown. Curve fittings were performed as described in the
legend to Fig. 2.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Activation of PRK by thioredoxins at 25 °C
Individual determinations of S0.5 and
Vmax are within 10% of the stated values.
|
|
 |
DISCUSSION |
The overarching goal of the present study was to compare the
kinetic efficiencies of Trx f and Trx m as
activators of oxidized PRK. If initial rate determinations are to be
valid and reproducible, the Trx must be maintained in its fully reduced
form, which can be achieved by the addition of an exogenous low
molecular weight thiol to the Trx reaction mixtures. However, the
incomplete and contradictory literature concerning activation of PRK by
thiols compelled us to screen several to identify appropriate
conditions for the Trx experiments. Of the three examined, only DTT met
the criterion of clearly discernible Trx-dependent
activation of PRK at a rate independent of the concentration of the
added thiol. Despite counter literature reports (31, 32), both BME and glutathione can also fully activate PRK; they do not, however, support
Trx-dependent activation, presumably because of their weaker reduction potentials, which allow build-up of oxidized Trx,
thereby driving the equilibrium in favor of oxidized PRK.
We were prompted to examine the activation of PRK by GSH in some detail
because of its high natural abundance in chloroplasts (4 mM) (33) and hence the obvious question of whether it might play some role in the regulation of PRK. The rate saturation kinetics relative to the concentration of GSH were unexpected. Reduction of the
PRK disulfide by a monothiol entails two consecutive bimolecular reactions: formation of a proteinS-SG mixed disulfide followed by
intermolecular displacement by GSH to form GSSG and the reduced protein. Irrespective of the relative rates of the two reactions, the
overall rate of PRK activation should be directly proportional to the
concentration of GSH. Our counterintuitive finding of rate saturation
argues that GSH and PRK form a noncovalent complex prior to the initial
sulfhydryl/disulfide exchange reaction. Although the apparent affinity
of GSH for PRK is rather weak (S0.5 = 24 mM), the activation Vmax (20 milliunits/min) is about 2-fold greater than the corresponding values
for either Trx. In these experiments, the concentration of GSSG should
increase stoichiometrically with PRK reduction. However, in
chloroplasts, the action of NADP-dependent glutathione
reductase maintains GSH predominantly in its reduced form. Thus, we
also examined the reduction of PRK by GSH in the presence of a fixed
concentration of 4 mM DTT. Under these conditions, the
S0.5 is decreased substantially to 5 mM, closely matching the concentration of GSH in
chloroplasts. This decrease likely reflects relief of inhibition of PRK
activation by GSSG. We attribute the apparent 2-fold drop in
Vmax to competition between DTT and GSH in their
interaction with PRK. This conclusion follows from the observation that
the Vmax, uncorrected for the contribution of
DTT alone, is about the same as the GSH-dependent
Vmax determined in the absence of DTT. The
kinetic parameters as determined for the activation of PRK by GSH are
not incompatible with the latter influencing the PRK activity levels in
chloroplasts; however, this possibility must be tempered by
measurements that indicate little fluctuation in the in vivo
concentration of GSH or the [GSH]/[GSSG] molar ratio (33).
With respect to kinetic characterizations of the activation of PRK by
Trx f and Trx m, our data clearly show that the
two thioredoxins are quite similar in their effectiveness with modest superiority of Trx m being attributable to an ~2-fold
greater Vmax. In the initial study of target
enzyme selectivity of chloroplasts thioredoxins at the time of their
discovery, Trx f was judged to be more effective than Trx
m in the activation of PRK (6). This judgment was based on a
2.5-fold greater end point activity that was attained with a single
concentration of Trx f in comparison to Trx m.
Separate experiments, again at single concentrations of thioredoxins,
actually showed only slightly faster rates of activation of PRK by Trx
f than by Trx m. Thus, the perpetuation of the
notion of clear-cut superiority of Trx f seems to have been
based on undue focus on one data set to the exclusion of the other. We
would also note that the use of impure preparations of thioredoxins and
an unstable form of PRK complexed with NADP-dependent glyceraldehyde-3-phosphate dehydrogenase in the prior investigation could have influenced the activation kinetics.
Although our present study is the first to provide a detailed
comparison of activation kinetics of PRK by Trx f and Trx
m, activation kinetics with Trx f have been
determined previously (34, 35). An apparent dissociation constant of
0.8 µM was reported for the PRK-Trx f complex
as calculated from the Trx concentration dependence of levels of
activated PRK reached at equilibrium. However, the rates of PRK
activation increased over the range from 1 to 10 µM (the
highest concentration examined) Trx and thus appear consistent with our
S0.5 of 17 µM.
In our prior study (10) of the relative effectiveness of Trx
f and Trx m as activators of
fructose-1,6-bisphosphatase and NADP-dependent malate
dehydrogenase, we included a number of site-directed mutants of Trx
f patterned after Trx m. The residues targeted for change or deletion at that time (Lys58,
Asn74, Gln75, and Asn77) appear
unique to Trx f, despite conservation of the corresponding residues among most thioredoxins including Trx m and
Escherichia coli Trx (36). We reasoned that such residues
are good candidates for participation in target protein recognition and
selectivity. Indeed, the mutants examined were generally more effective
than wild-type Trx f in the activation of malate
dehydrogenase but less effective in the activation of
fructose-1,6-bisphosphatase. Comparative structural considerations also
prompted the inclusion of the T105I and V89I/T105I mutants of Trx
f in the present study of PRK activation.
Three-dimensional structures show Lys58 to be near the
active site and Asn74, Gln75, and
Asn77 to be near a conserved, putative hydrophobic contact
surface (37-39). Residues 89 and 105 are components of this surface
and are located in loops that oppose the active site (36, 40, 41). The
formation of a disulfide bond in Trx appears to make these loops
"more rigid" (42). Based on structures of E. coli Trx,
the side chain and backbone of Ile75 (Val89 in
spinach Trx f) make contact with the disulfide bond but,
upon reduction, the C
of Ile75 swings out
(39). Structural data on human Trx with either one of its two targets
(NF
B and Ref-1) are supportive of the theory that Val89
and Thr105 are available for interaction with target
enzymes. Specifically, Thr74 (Val89 in Trx
f) forms a hydrophobic interaction with Tyr60 of
NF
B/Trp67 of Ref-1, and a hydrophobic interaction also
exists between Ser90 of human Trx (Thr105 of
Trx f) and Glu63 of NF
B/Ile64 of
Ref-1. In addition, both the backbone amide of Thr74 of
human Trx and the hydroxyl of Ser90 are hydrogen bonded to
the target (43, 44). The report on the structure of an
Anabaena Trx also proposes Val89 as a contact
site based on structural comparisons to other thioredoxins and modeling
studies with spinach NADP-dependent malate dehydrogenase and
fructose-1,6-bisphosphatase (45).
In contrast to the 500-fold superiority of Trx f
versus Trx m as an activator of
fructose-1,6-bisphosphatase, the differential effectiveness favors Trx
m by only 2-fold in the activation of PRK. Thus, we assumed
that the kinetic parameters of Trx f would not be
drastically impacted by single amino acid substitutions or deletions
that mimic the corresponding positions of Trx m. Mutagenesis
at positions 74, 75, and 77 does lead to modest increases in
Vmax values in the activation of PRK, thus
rendering the mutants more akin to Trx m. However, these
improvements are offset by increased S0.5
values, whereby the efficiencies differ little from that of wild-type
Trx f. In contrast, the efficiencies displayed by Trx
f-T105I and Trx f-V89I/T105I closely resemble
that of wild-type Trx m because of substantial increases in
Vmax. Interestingly, these two mutants also
mimic Trx m with respect to activation of
fructose-1,6-bisphosphatase, but the altered efficiencies primarily reflect S0.5 values (46). In fact, the affinity
of the double mutant for the phosphatase is reduced nearly 50-fold
relative to wild-type Trx f. Therefore, residues at
positions 89 and 105 in spinach Trx f clearly impact the
ability of the protein to interact with and activate target enzymes.
In addition to our studies on target protein selectivity of chloroplast
thioredoxins, another laboratory reported a 6-fold more rapid rate of
activation of chloroplast ATP synthase by Trx f than by Trx
m (47). Of the four target proteins whose activation kinetics have thus far been quantified, three are more responsive to
Trx f, and one is similarly responsive to both thioredoxins. Thus, any indispensable biological need for chloroplast Trx
m does not appear to reflect redox regulation of enzymes.
Indeed, a thioredoxin of cyanobacteria, which is highly homologous to higher plant Trx m, is required for both photosynthetic and
heterotrophic growth (48, 49). We speculate that major roles of Trx
m in plants remain to be elucidated.
Beyond the usual caveat of extending in vitro findings to
events that occur in vivo, PRK presents a particular
challenge. As emphasized, our studies were carried out with highly
purified, homodimeric PRK from spinach. Although numerous independent
studies suggest that in vivo chloroplast PRK is part of a
multienzyme complex, an accurate description of the complex as present
in chloroplasts is rendered problematic because of qualitative
variation of the composition of the isolated complexes (2, 50-60). The PRK within the 5-protein complex
PRK-Rubisco-phosphoriboisomerase-glyceraldehyde-3-phosphate dehydrogenase-phosphoglycerate kinase has been reported to be more
readily activated by Trx f than is free PRK (34, 35). To
explore the possibility that the association of PRK with other proteins
might substantially alter the relative efficiencies of activation by
the two thioredoxins, we tested the effect of Rubisco (the most
abundant chloroplast protein) on activation of PRK by Trx f
and Trx m. The absence of altered activation kinetics in the
presence of Rubisco argues against any unique requirement for Trx
m, even if activation occurs only at the complex level in vivo. However, the presence of homodimeric PRK in fresh
plant extracts (61), the inherent instability of the PRK-containing multienzyme complexes (Ref. 58; additional reports reviewed extensively
in Ref. 30), the dissociation of these complexes by thiols (32, 53,
57-59) and NADPH (59, 62), and the calculated dissociation constant of
the PRK-glyceraldehyde-3-phosphate dehydrogenase complex (58) indicate
that at least a portion of the chloroplast PRK exists in uncomplexed
form and would be available for interaction with thioredoxins. Thus, we
believe that our studies on the activation of purified PRK are
justified and that the derived data will provide a relevant basis of
comparison in future studies with complexed PRK once the in
vivo status of this enzyme is better understood.
 |
FOOTNOTES |
*
This work was supported jointly by the U.S. Department of
Agriculture under Grant 96-35306-3412 from the National Research Initiative Competitive Grants Program and by the Office of Biological and Environmental Research, U.S. Department of Energy under Contract DE-AC0596OR22464 with Lockheed Martin Energy Research Corp.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Molecular and Cell Biology, University of
California, Berkeley, CA 94720.
To whom correspondence should be addressed. Present address:
Dept. of Biochemistry and Cellular and Molecular Biology, University of
Tennessee, Knoxville, TN 37996. Tel.: 865-574-0959; Fax: 865-574-0793; E-mail: ffh@ornl.gov.
Published, JBC Papers in Press, April 4, 2000, DOI 10.1074/jbc.M001936200
 |
ABBREVIATIONS |
The abbreviations used are:
Trx, thioredoxin;
Bicine, N,N'-bis-(2-hydroxyethyl)glycine;
BME, 2-mercaptoethanol;
DTNB, 5,5'-dithiobis-(2-nitrobenzoic acid);
DTT, dithiothreitol;
GSH, reduced
glutatione;
GSSG, oxidized glutathione;
PRK, phosphoribulokinase;
Rubisco, D-ribulose-1,5-bisphosphate
carboxylase/oxygenase.
 |
REFERENCES |
| 1.
|
Wolosiuk, R. A.,
and Buchanan, B. B.
(1977)
Nature
263,
257-258
|
| 2.
|
Wolosiuk, R. A.,
and Buchanan, B. B.
(1978)
Arch. Biochem. Biophys.
189,
97-101
|
| 3.
|
Buchanan, B. B.
(1991)
Arch. Biochem. Biophys.
288,
1-9
|
| 4.
|
Jacquot, J.-P.,
Lancelin, J.-M.,
and Meyer, Y.
(1997)
New Phytol.
136,
543-570
|
| 5.
|
Buchanan, B. B.
(1980)
Annu. Rev. Plant Physiol. Plant Mol. Biol.
31,
341-374
|
| 6.
|
Wolosiuk, R. A.,
Crawford, N. A.,
Yee, B. C.,
and Buchanan, B. B.
(1979)
J. Biol. Chem.
254,
1627-1632
|
| 7.
|
Jacquot, J.-P.,
Vidal, J.,
Gadal, P.,
and Schürmann, P.
(1978)
FEBS Lett.
96,
243-246
|
| 8.
|
Scheibe, R.,
and Anderson, L. E.
(1981)
Biochim. Biophys. Acta
636,
58-64
|
| 9.
|
Buchanan, B. B.
(1986)
in
Thioredoxin and Glutaredoxin Systems: Structure and Function
(Holmgren, A.
, Bränden, C.-I.
, Jörnvall, H.
, and Sjöberg, B.-M., eds)
, pp. 233-242, Raven Press, New York
|
| 10.
|
Geck, M. K.,
Larimer, F. W.,
and Hartman, F. C.
(1996)
J. Biol. Chem.
271,
24736-24740
|
| 11.
|
Porter, M. A.,
Milanez, S.,
Stringer, C. D.,
and Hartman, F. C.
(1986)
Arch. Bioch. Biophys.
245,
14-23
|
| 12.
|
Porter, M. A.,
Stringer, C. D.,
and Hartman, F. C.
(1988)
J. Biol. Chem.
263,
123-129
|
| 13.
|
Brandes, H. K.,
Hartman, F. C.,
Lu, T.-Y.,
and Larimer, F. W.
(1996)
J. Biol. Chem.
271,
6490-6496
|
| 14.
|
Brandes, H. K.,
Stringer, C. D.,
and Hartman, F. C.
(1992)
Biochemistry
31,
12833-12838
|
| 15.
|
Latzko, E.,
Garnier, R.,
and Gibbs, M.
(1970)
Biochem. Biophys. Res. Commun.
39,
1140-1144
|
| 16.
|
Avron, M.,
and Gibbs, M.
(1974)
Plant Physiol.
53,
136-139
|
| 17.
|
Champigny, M.-L.,
and Bismuth, E.
(1976)
Physiol. Plant.
35,
95-100
|
| 18.
|
Fischer, K.,
and Latzko, E.
(1979)
Biochem. Biophys. Res. Commun.
89,
300-306
|
| 19.
|
Laing, W. A.,
Stitt, M.,
and Heldt, H. W.
(1981)
Biochim. Biophys. Acta
637,
348-359
|
| 20.
|
Brandes, H. K.,
Larimer, F. W.,
and Hartman, F. C.
(1996)
J. Biol. Chem.
271,
3333-3335
|
| 21.
|
Wishnick, M.,
and Lane, M. D.
(1971)
Methods Enzymol.
23,
570-577
|
| 22.
|
Hirasawa, M.,
Brandes, H. K.,
Hartman, F. C.,
and Knaff, D. B.
(1998)
Arch. Biochem. Biophys.
350,
127-131
|
| 23.
|
Hirasawa, M.,
Schürmann, P.,
Jacquot, J.-P.,
Manieri, W.,
Jacquot, P.,
Keryer, E.,
Hartman, F. C.,
and Knaff, D. B.
(1999)
Biochemistry
38,
5200-5205
|
| 24.
|
Szajewski, R. P.,
and Whitesides, G. M.
(1980)
J. Am. Chem. Soc.
102,
2011-2026
|
| 25.
|
Gilbert, H. F.
(1990)
Adv. Enzymol.
63,
69-172
|
| 26.
|
Lees, W. J.,
and Whitesides, G. M.
(1993)
J. Org. Chem.
58,
642-647
|
| 27.
|
Schürmann, P.,
Maeda, K.,
and Tsugita, A.
(1981)
Eur. J. Biochem.
116,
37-45
|
| 28.
|
de Lamotte-Guery, F.,
Miginiac-Maslow, M.,
Decottignies, P.,
Stein, M.,
Minard, P.,
and Jacquot, J.-P.
(1991)
Eur. J. Biochem.
196,
287-294
|
| 29.
|
Hatch, M. D.,
and Agostino, A.
(1992)
Plant Physiol.
100,
360-366
|
| 30.
|
Romanova, A. K.,
and Pavlovets, V. V.
(1997)
Russian J. Plant Physiol.
44,
230-238
|
| 31.
|
Wolosiuk, R. A.,
Corley, E.,
Crawford, N.,
and Buchanan, B. B.
(1985)
FEBS Lett.
189,
212-216
|
| 32.
|
Clasper, S.,
Chelvarajan, R.,
Easterby, J. S.,
and Powls, R.
(1994)
Biochim. Biophys. Acta
1209,
101-106
|
| 33.
|
Law, M.,
Charles, S.,
and Halliwell, B.
(1983)
Biochem. J.
210,
899-903
|
| 34.
|
Rault, M.,
Gontero, B.,
and Ricard, J.
(1991)
Eur. J. Biochem.
197,
791-797
|
| 35.
|
Gontero, B.,
Mulliert, G.,
Rault, M.,
Giudici-Orticoni, M.-T.,
and Ricard, J.
(1993)
Eur. J. Biochem.
217,
1075-1082
|
| 36.
|
Eklund, H.,
Gleason, F.,
and Holmgren, A.
(1991)
Proteins Struct. Funct. Genet.
11,
13-28
|
| 37.
|
Dyson, H. J.,
Gippert, G. P.,
Case, D. A.,
Holmgren, A.,
and Wright, P. E.
(1990)
Biochemistry
29,
4129-4136
|
| 38.
|
Katti, S. K.,
LeMaster, D. M.,
and Eklund, H.
(1990)
J. Mol. Biol.
212,
167-184
|
| 39.
|
Jeng, M.-F.,
Campbell, A. P.,
Begley, T.,
Holmgren, A.,
Case, D. A.,
Wright, P. E.,
and Dyson, H. J.
(1994)
Structure
2,
853-868
|
| 40.
|
Holmgren, A.
(1985)
Annu. Rev. Biochem.
54,
237-271
|
| 41.
|
Xia, T.-H.,
Bushweller, J. H.,
Sodano, P.,
Billeter, M.,
Björnberg, O.,
Holmgren, A.,
and Wüthrich, K.
(1992)
Protein Sci.
1,
310-321
|
| 42.
|
Qin, J.,
Clore, G. M.,
and Gronenborn, A. M.
(1994)
Structure
2,
503-522
|
| 43.
|
Qin, J.,
Clore, G. M.,
Poindexter Kennedy, W. M.,
Huth, J. R.,
and Gronenborn, A. M.
(1995)
Structure
3,
289-297
|
| 44.
|
Qin, J.,
Clore, G. M.,
Poindexter Kennedy, W. M.,
Kuszewski, J.,
and Gronenborn, A. M.
(1996)
Structure
4,
613-620
|
| 45.
|
Saarinen, M.,
Gleason, F. K.,
and Eklund, H.
(1995)
Structure
3,
1097-1108
|
| 46.
|
Geck, M. K.
(1997)
Characterization of the Thioredoxin-modulated Regulation of Fructose-1,6-bisphosphatase, NADP-dependent Malate Dehydrogenase, and Phosphoribulokinase.Doctoral Dissertation
, University of Tennessee, Knoxville, TN
|
| 47.
|
Schwarz, O.,
Schürmann, P.,
and Strotmann, H.
(1997)
J. Biol. Chem.
272,
16924-16927
|
| 48.
|
Muller, E. G. D.,
and Buchanan, B. B.
(1989)
J. Biol. Chem.
264,
4008-4014
|
| 49.
|
Navarro, F.,
and Florencio, F. J.
(1996)
Plant Physiol.
111,
1067-1075
|
| 50.
|
Sainis, J. K.,
Merriam, K.,
and Harris, G. C.
(1989)
Plant Physiol.
89,
368-374
|
| 51.
|
Sainis, J. K.,
and Harris, G. C.
(1986)
Biochem. Biophys. Res. Commun.
139,
947-954
|
| 52.
|
Rault, M.,
Giudici-Orticoni, M.-T.,
Gontero, B.,
and Ricard, J.
(1993)
Eur. J. Biochem.
217,
1065-1073
|
| 53.
|
Gontero, B.,
Cardenas, M.,
and Ricard, J.
(1988)
Eur. J. Biochem.
173,
437-443
|
| 54.
|
Süss, K.-H.,
Arkona, C.,
Manteuffel, R.,
and Adler, K.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5514-5518
|
| 55.
|
Nicholson, S.,
Easterby, J. S.,
and Powls, R.
(1986)
FEBS Lett.
202,
19-22
|
| 56.
|
Nicholson, S.,
Easterby, J. S.,
and Powls, R.
(1987)
Eur. J. Biochem.
162,
423-431
|
| 57.
|
Clasper, S.,
Easterby, J. S.,
and Powls, R.
(1991)
Eur. J. Biochem.
202,
1239-1246
|
| 58.
|
Avilan, L.,
Gontero, B.,
Lebreton, S.,
and Ricard, J.
(1997)
Eur. J. Biochem.
246,
78-84
|
| 59.
|
Wedel, N.,
Soll, J.,
and Paap, B. K.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
10479-10484
|
| 60.
|
Pohlmeyer, K.,
Paap, B. K.,
Soll, J.,
and Wedel, N.
(1996)
Plant Mol. Biol.
32,
969-978
|
| 61.
|
Porter, M. A.
(1990)
Planta
181,
349-357
|
| 62.
|
Wedel, N.,
and Soll, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9699-9704
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Marri, M. Zaffagnini, V. Collin, E. Issakidis-Bourguet, S. D. Lemaire, P. Pupillo, F. Sparla, M. Miginiac-Maslow, and P. Trost
Prompt and Easy Activation by Specific Thioredoxins of Calvin Cycle Enzymes of Arabidopsis thaliana Associated in the GAPDH/CP12/PRK Supramolecular Complex
Mol Plant,
October 3, 2008;
(2008)
ssn061v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Michels, N. Wedel, and P. G. Kroth
Diatom Plastids Possess a Phosphoribulokinase with an Altered Regulation and No Oxidative Pentose Phosphate Pathway
Plant Physiology,
March 1, 2005;
137(3):
911 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lebreton, E. Graciet, and B. Gontero
Modulation, via Protein-Protein Interactions, of Glyceraldehyde-3-phosphate Dehydrogenase Activity through Redox Phosphoribulokinase Regulation
J. Biol. Chem.,
March 28, 2003;
278(14):
12078 - 12084.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.